Supported by the Li Ka Shing Foundation’s Love Can Help Scheme, this programme introduces Histotripsy as a non-invasive treatment option for eligible Hepatocellular Carcinoma (HCC) patients in Hong Kong. It aims to provide financial assistance to Hong Kong permanent residents who are suitable for Histotripsy treatment but may lack sufficient financial means or insurance coverage.

At Gleneagles Hospital Hong Kong, we are pleased to support this initiative and contribute to expanding access to such innovative treatment options for patients in need.

Histotripsy is a non-invasive treatment that uses focused ultrasound waves to mechanically break down targeted tumour tissue without the need for surgical incision. For more details, please visit here.

Applicants should meet the following requirements:

General Requirements

• Hong Kong permanent resident
• Aged 22 or above
• Diagnosed with Hepatocellular Carcinoma (HCC)
• No relevant insurance coverage
• Demonstrated financial need

Clinical Criteria

• Tumour status: Unresectable HCC (<3 lesions, largest <3 cm)
• Renal function: Normal (eGFR > 90)
• Coagulation: Acceptable (INR < 1.5; Platelet > 70)
• Medication: Able to withhold anticoagulants / anti-platelet drugs for 5 days
• General health: Fit for general anaesthesia
• Treatment history: Completed at least one course of standard treatment in a Hong Kong public hospital

Step 1 – Submit Preliminary Screening Form

Please complete the Application Form (For preliminary screening).

• Submit to one participating hospital only
• An acknowledgment email will be sent upon successful submission
      

Step 2 – Preliminary Assessment

The hospital will review submitted information and may contact applicants for follow-up.

Step 3 – Ultrasound Screening & Consultation

Eligible applicants will be required to undergo an ultrasound scan and medical consultation at their own expense.

Step 4 – Treatment Arrangement

Patients who are assessed as suitable and opt for Histotripsy will proceed with treatment arrangement.

• Assessment-related fees
  Applicants are required to pay out-of-pocket for assessment-related services. The estimated total fee ranges from HKD 4,300 to 5,400, which includes specialist consultation and liver ultrasound examination.
   
• Histotripsy treatment
  Under the scheme, eligible patients who choose to undergo Histotripsy will be required to pay a subsidised fee of HKD 50,000, payable directly to the hospital.

• Submission of the form constitutes consent for the use of personal and medical data for preliminary assessment
• The hospital will contact applicants directly for further arrangements
• Applicants are required to declare absence of relevant insurance coverage and confirm financial need
• Additional investigations or follow-up imaging may be recommended as part of clinical care, subject to discussion between doctor and patient
• Final eligibility and treatment decisions are subject to clinical assessment by the hospital

Application Form (For preliminary screening)